Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia

DSpace Repository

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia

Author: Pfeifer, H.; Wassmann, B.; Bethge, W.; Dengler, J.; Bornhaeuser, M.; Stadler, M.; Beelen, D.; Vucinic, V.; Burmeister, T.; Stelljes, M.; Faul, C.; Dreger, P.; Kiani, A.; Schaefer-Eckart, K.; Schwerdtfeger, R.; Lange, E.; Kubuschok, B.; Horst, H. A.; Gramatzki, M.; Brueck, P.; Serve, H.; Hoelzer, D.; Goekbuget, N.; Ottmann, O. G.
Tübinger Autor(en):
Bethge, Wolfgang Andreas
Faul, Christoph
Published in: Leukemia (2013), Bd. 27, H. 6, S. 1254-1262
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/leu.2012.352
ISSN: 0887-6924
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)